Frontiers in Psychiatry | Psychopharmacology

Original Research

Published on 13 May 2025

Drug-drug interaction of paroxetine on olanzapine and initial dosage optimization in patients with major depressive disorder based on population pharmacokinetics

in Psychopharmacology

Cun Zhang
Liang Chen
Yin-Yin Duan
Su-Mei He
Ya-Li Tian
Ying Gao
Dong-Dong Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1538996

139 views

Case Report

Published on 01 May 2025

The role of dulaglutide in the treatment of alcohol use disorder: a case report

in Psychopharmacology

Olivia Hill
Sarah Hughes
Aakanksha Singh
Michael Ang-Rabanes
Raja Mogallapu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1420316

564 views

Review

Published on 28 Apr 2025

Benzos (as) needed: research into as-needed and intermittent benzodiazepines for anxiety is required for comprehensive best prescribing practices

in Psychopharmacology

Arthur Krieger

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1569416

693 views

Editorial

Published on 23 Apr 2025

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics

in Psychopharmacology

Martin L. Williams
Deborah Rudin
Yasmin Schmid
Jacqueline von Salm

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1600812

879 views

Systematic Review

Published on 15 Apr 2025

Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis

in Psychopharmacology

Hao-Yan Li
Wen-Jing Xu
Ya-Mei Wang
Shuang Xie
Huan-Liang Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1476449

801 views

Case Report

Published on 09 Apr 2025

Acute myasthenia caused by lithium: a case report

in Psychopharmacology

Jiashu Yao
Ruihuan Ye
Xihao Mao
Mingmin Jin
Rong Yan
Yuedi Shen
Ning Dai
Wei Chen

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1467267

637 views

Opinion

Published on 08 Apr 2025

Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization

in Psychopharmacology

Jennifer L. Jones

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1565852

1,583 views

Original Research

Published on 27 Mar 2025

Estimating the incidence of actionable drug-gene interactions in Japanese patients with major depressive disorder

in Psychopharmacology

Masakazu Hatano
Masashi Ikeda
Takeo Saito
Masami Miyata
Nakao Iwata
Shigeki Yamada

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1542000

884 views

Editorial

Published on 14 Mar 2025

Editorial: Safety and side effects of psychotropic medications, volume III

in Psychopharmacology

Renato de Filippis
Mireia Solerdelcoll
Mohammadreza Shalbafan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1562008

621 views

Mini Review

Published on 12 Mar 2025

Could antidepressants increase mood and immunity at the same time?

in Psychopharmacology

Francis Lavergne
Therese M. Jay

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1340179

1,211 views

Original Research

Accepted on 07 Mar 2025

Postmarketing Safety Assessment of the Novel Postpartum Depression Drug, Zuranolone: Evidence from Real-World Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System (FAERS)

in Psychopharmacology

Duoqin Huang
Zixin Luo
Xi Gong
Kang Zou
Yu Peng

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1517773

199 views

Brief Research Report

Published on 05 Mar 2025

Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening

in Psychopharmacology

Luke R. Cavanah
Parita K. Ray
Jessica L. Goldhirsh
Leighton Y. Huey
Brian J. Piper

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1450111

687 views

Original Research

Published on 04 Mar 2025

Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y)

in Psychopharmacology

Sofía Manchado Perero
Ana Rodríguez Lorente
Alba García-Pérez
Guillermo Isidro García
Luis Alberto Forcen-Muñoz
Santiago Ovejero García
Rocío Sáez Povedano
Ana Luisa González-Galdámez
Laura Mata Iturralde
Mariluz Ramirez Bonilla

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1540213

1,441 views

Original Research

Published on 03 Mar 2025

Exposure and response prevention versus risperidone for the treatment of tic disorders: a randomized controlled trial

in Psychopharmacology

Jolande M. T. M. van de Griendt
Danielle C. Cath
Agnes A. A. C. M. Wertenbroek
Cara W. J. Verdellen
Judith J. G. Rath
Irene G. Klugkist
Sebastiaan F. T. M. de Bruijn
Marc J. P. M. Verbraak

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1360895

1,233 views

Editorial

Published on 13 Feb 2025

Editorial: Case reports in psychopharmacology, volume II

in Psychopharmacology

Matej Stuhec
Patricia Di Ciano

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1554037

601 views

Original Research

Published on 05 Feb 2025

Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence

in Psychopharmacology

Fernando Mora
Carlos Gómez Sánchez-Lafuente
Mariano De Iceta
Carolina Roset
Antonio Cárdenas
Daniel Pérez
Elena Álvarez-Barón
Irene Gabarda-Inat
Savana Research Group

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1506142

1,580 views